Interferon beta-1b (Betaseron/Extavia) is a recombinant human interferon that binds to type I interferon receptors (IFNAR1 and IFNAR2) and is FDA-approved as an immunosuppressant to treat relapsing-remitting forms of multiple sclerosis [98,99]. This evidence concerns the gene IFNAR2 and multiple sclerosis.